Vanguard Group Inc Caribou Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,618,268 shares of CRBU stock, worth $8.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,618,268

Previous 4,544,706 1.62%

Holding current value

$8.31 Million

Previous $7.45 Million 20.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.56 - $2.73 $114,756 - $200,824	73,562 Added 1.62%	4,618,268 $9.01 Million
Q2 2024 Aug 13, 2024	BUY	$1.62 - $5.05 $702,935 - $2.19 Million	433,911 Added 10.56%	4,544,706 $7.45 Million
Q1 2024 May 10, 2024	BUY	$4.82 - $8.26 $716,979 - $1.23 Million	148,751 Added 3.75%	4,110,795 $21.1 Million
Q4 2023 Feb 14, 2024	BUY	$3.58 - $6.25 $500,816 - $874,331	139,893 Added 3.66%	3,962,044 $22.7 Million
Q3 2023 Nov 14, 2023	BUY	$4.08 - $8.14 $5.15 Million - $10.3 Million	1,261,920 Added 49.29%	3,822,151 $18.3 Million
Q2 2023 Aug 14, 2023	SELL	$4.04 - $5.47 $185,153 - $250,690	-45,830 Reduced 1.76%	2,560,231 $10.9 Million
Q1 2023 May 15, 2023	BUY	$4.3 - $7.78 $111,129 - $201,066	25,844 Added 1.0%	2,606,061 $13.8 Million
Q4 2022 Feb 10, 2023	BUY	$5.57 - $11.01 $149,214 - $294,946	26,789 Added 1.05%	2,580,217 $16.2 Million
Q3 2022 Nov 14, 2022	BUY	$5.34 - $12.79 $3 Million - $7.18 Million	561,065 Added 28.16%	2,553,428 $26.9 Million
Q2 2022 Aug 12, 2022	SELL	$5.1 - $9.74 $46,874 - $89,520	-9,191 Reduced 0.46%	1,992,363 $10.8 Million
Q1 2022 May 13, 2022	BUY	$8.42 - $15.32 $9.15 Million - $16.7 Million	1,087,038 Added 118.86%	2,001,554 $18.4 Million
Q4 2021 Feb 14, 2022	SELL	$14.59 - $23.26 $319,287 - $509,021	-21,884 Reduced 2.34%	914,516 $13.8 Million
Q3 2021 Nov 12, 2021	BUY	$15.75 - $30.29 $14.7 Million - $28.4 Million	936,400 New	936,400 $22.4 Million

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

52.6M

Call Options Held

148K

Put Options Held

70.7K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $110M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Caribou Biosciences, Inc. Transaction History